Annual ROE
-185.02%
+86.29%+31.80%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual return on equity is -185.02%, with the most recent change of +86.29% (+31.80%) on December 31, 2023.
- During the last 3 years, ABVC annual ROE has risen by +586.77% (+76.03%).
- ABVC annual ROE is now -107.67% below its all-time high of 2411.79%, reached on December 31, 2019.
Performance
ABVC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-101.80%
+75.14%+42.47%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly return on equity is -101.80%, with the most recent change of +75.14% (+42.47%) on September 30, 2024.
- Over the past year, ABVC quarterly ROE has increased by +215.08% (+67.87%).
- ABVC quarterly ROE is now -103.36% below its all-time high of 3028.85%, reached on March 31, 2007.
Performance
ABVC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABVC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.8% | +67.9% |
| 3 y3 years | +76.0% | +76.4% |
| 5 y5 years | -359.4% | +76.4% |
ABVC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | at high | +70.0% |
| 5 y | 5-year | -107.7% | +76.0% | -108.0% | +98.8% |
| alltime | all time | -107.7% | +93.5% | -103.4% | +98.8% |
ABVC BioPharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -101.80%(-42.5%) |
| Jun 2024 | - | -176.94%(-27.0%) |
| Mar 2024 | - | -242.35%(+0.5%) |
| Dec 2023 | -185.02%(-31.8%) | -241.23%(-23.9%) |
| Sep 2023 | - | -316.88%(-2.5%) |
| Jun 2023 | - | -324.89%(+44.3%) |
| Mar 2023 | - | -225.16%(-5.8%) |
| Dec 2022 | -271.31%(+21.8%) | -239.12%(-5.1%) |
| Sep 2022 | - | -251.86%(-4.0%) |
| Jun 2022 | - | -262.44%(-22.7%) |
| Mar 2022 | - | -339.63%(+13.0%) |
| Dec 2021 | -222.66%(-71.2%) | -300.44%(-30.4%) |
| Sep 2021 | - | -431.46%(-80.0%) |
| Jun 2021 | - | -2156.58%(-74.0%) |
| Mar 2021 | - | -8301.40%(+46.6%) |
| Dec 2020 | -771.79%(-132.0%) | -5663.69%(-781.5%) |
| Sep 2020 | - | 831.04%(-34.6%) |
| Jun 2020 | - | 1271.46%(+205.8%) |
| Mar 2020 | - | 415.77%(+144.5%) |
| Dec 2019 | 2411.79%(+3281.2%) | 170.03%(+23.9%) |
| Sep 2019 | - | 137.26%(+40.6%) |
| Jun 2019 | - | 97.61%(-7.9%) |
| Mar 2019 | - | 105.98%(-20.1%) |
| Dec 2018 | 71.33%(-70.5%) | 132.63%(+27.1%) |
| Sep 2018 | - | 104.37%(-61.8%) |
| Jun 2018 | - | 273.29%(-8.7%) |
| Mar 2018 | - | 299.29%(-9.7%) |
| Dec 2017 | 241.50%(-17.4%) | 331.42%(+101.1%) |
| Sep 2017 | - | 164.80%(+357.5%) |
| Sep 2017 | 292.30%(+69.4%) | - |
| Jun 2017 | - | 36.02%(-21.7%) |
| Mar 2017 | - | 46.02%(-84.4%) |
| Dec 2016 | - | 295.85%(-73.8%) |
| Sep 2016 | 172.56%(-1877.1%) | 1129.41%(-167.7%) |
| Jun 2016 | - | -1668.83%(-46.4%) |
| Mar 2016 | - | -3115.72%(+38.7%) |
| Dec 2015 | - | -2245.99%(>+9900.0%) |
| Sep 2015 | -9.71%(+2934.4%) | -21.44%(+357.1%) |
| Jun 2015 | - | -4.69%(>+9900.0%) |
| Mar 2015 | - | -0.02%(-118.2%) |
| Dec 2014 | - | 0.11%(>+9900.0%) |
| Sep 2014 | -0.32% | 0.00%(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | 0.00%(-100.0%) |
| Mar 2014 | - | 5.50%(-50.5%) |
| Dec 2013 | - | 11.11%(-43.1%) |
| Sep 2013 | 12.04%(-81.5%) | 19.54%(-36.6%) |
| Jun 2013 | - | 30.83%(-26.6%) |
| Mar 2013 | - | 42.03%(-30.3%) |
| Dec 2012 | - | 60.28%(-17.9%) |
| Sep 2012 | 65.07%(-21.8%) | 73.42%(-22.7%) |
| Jun 2012 | - | 94.98%(-30.4%) |
| Mar 2012 | - | 136.43%(+78.5%) |
| Dec 2011 | - | 76.44%(+16.7%) |
| Sep 2011 | 83.26%(+31.1%) | 65.48%(+29.6%) |
| Jun 2011 | - | 50.53%(+145.3%) |
| Mar 2011 | - | 20.60%(-60.6%) |
| Dec 2010 | - | 52.35%(-28.5%) |
| Sep 2010 | 63.50%(-75.4%) | 73.17%(-26.2%) |
| Jun 2010 | - | 99.16%(-24.2%) |
| Mar 2010 | - | 130.78%(-17.9%) |
| Dec 2009 | - | 159.20%(-39.1%) |
| Sep 2009 | 257.73%(-52.8%) | 261.21%(-16.3%) |
| Jun 2009 | - | 312.17%(-17.4%) |
| Mar 2009 | - | 377.79%(-22.4%) |
| Dec 2008 | - | 486.82%(-4.2%) |
| Sep 2008 | 546.08%(-119.1%) | 508.31%(+24.7%) |
| Jun 2008 | - | 407.48%(-41.6%) |
| Mar 2008 | - | 698.08%(-35.8%) |
| Dec 2007 | - | 1087.21%(-32.4%) |
| Sep 2007 | -2857.13%(+5296.9%) | - |
| Jun 2007 | - | 1607.66%(-46.9%) |
| Mar 2007 | - | 3028.85%(+17.9%) |
| Dec 2006 | -52.94%(+46.9%) | 2569.69%(-196.2%) |
| Sep 2006 | - | -2670.41%(+5431.1%) |
| Jun 2006 | - | -48.28%(+25.7%) |
| Mar 2006 | - | -38.41%(+6.4%) |
| Dec 2005 | -36.04%(-1321.7%) | -36.09%(+14.4%) |
| Sep 2005 | - | -31.55%(-1489.9%) |
| Jun 2005 | - | 2.27%(-222.0%) |
| Mar 2005 | - | -1.86%(-161.2%) |
| Dec 2004 | 2.95%(-109.8%) | 3.04%(-71.9%) |
| Sep 2004 | - | 10.83%(-168.9%) |
| Jun 2004 | - | -15.71%(+161.8%) |
| Mar 2004 | - | -6.00% |
| Dec 2003 | -29.95% | - |
FAQ
- What is ABVC BioPharma annual return on equity?
- What is the all time high annual ROE for ABVC BioPharma?
- What is ABVC BioPharma annual ROE year-on-year change?
- What is ABVC BioPharma quarterly return on equity?
- What is the all time high quarterly ROE for ABVC BioPharma?
- What is ABVC BioPharma quarterly ROE year-on-year change?
What is ABVC BioPharma annual return on equity?
The current annual ROE of ABVC is -185.02%
What is the all time high annual ROE for ABVC BioPharma?
ABVC BioPharma all-time high annual return on equity is 2411.79%
What is ABVC BioPharma annual ROE year-on-year change?
Over the past year, ABVC annual return on equity has changed by +86.29% (+31.80%)
What is ABVC BioPharma quarterly return on equity?
The current quarterly ROE of ABVC is -101.80%
What is the all time high quarterly ROE for ABVC BioPharma?
ABVC BioPharma all-time high quarterly return on equity is 3028.85%
What is ABVC BioPharma quarterly ROE year-on-year change?
Over the past year, ABVC quarterly return on equity has changed by +215.08% (+67.87%)